Cargando…
Recombinant GPEHT Fusion Protein Derived from HTLV-1 Proteins with Alum Adjuvant Induces a High Immune Response in Mice
The human T-cell leukemia virus type 1 (HTLV-1) is a positive single-stranded RNA virus that belongs to the delta retrovirus family. As a result, a vaccine candidate that can be recognized by B cells and T cells is a good candidate for generating a durable immune response. Further, the GPEHT protein...
Autores principales: | Jahantigh, Hamid Reza, Stufano, Angela, Koohpeyma, Farhad, Nikbin, Vajihe Sadat, Shahosseini, Zahra, Lovreglio, Piero |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865465/ https://www.ncbi.nlm.nih.gov/pubmed/36679960 http://dx.doi.org/10.3390/vaccines11010115 |
Ejemplares similares
-
An Epitope Platform for Safe and Effective HTLV-1-Immunization: Potential Applications for mRNA and Peptide-Based Vaccines
por: Lucchese, Guglielmo, et al.
Publicado: (2021) -
Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review
por: Stufano, Angela, et al.
Publicado: (2021) -
The Candidate Antigens to Achieving an Effective Vaccine against Staphylococcus aureus
por: Jahantigh, Hamid Reza, et al.
Publicado: (2022) -
Case Report: Mutation in AIMP2/P38, the Scaffold for the Multi-Trna Synthetase Complex, and Association With Progressive Neurodevelopmental Disorders
por: Mazaheri, Mahta, et al.
Publicado: (2022) -
Engineered immunogen binding to alum adjuvant enhances humoral immunity
por: Moyer, Tyson J., et al.
Publicado: (2020)